Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$12.2 - $18.71 $133,712 - $205,061
-10,960 Reduced 2.5%
427,763 $7.47 Million
Q2 2022

Aug 15, 2022

SELL
$12.05 - $22.74 $35,065 - $66,173
-2,910 Reduced 0.66%
438,723 $5.79 Million
Q1 2022

May 16, 2022

SELL
$18.32 - $23.03 $155,390 - $195,340
-8,482 Reduced 1.88%
441,633 $9.98 Million
Q4 2021

Feb 14, 2022

SELL
$18.75 - $24.8 $415,331 - $549,344
-22,151 Reduced 4.69%
450,115 $10 Million
Q3 2021

Nov 15, 2021

SELL
$19.65 - $31.89 $10.1 Million - $16.4 Million
-515,681 Reduced 52.2%
472,266 $10.1 Million
Q2 2021

Aug 16, 2021

BUY
$29.4 - $35.96 $2.29 Million - $2.8 Million
77,901 Added 8.56%
987,947 $31.1 Million
Q1 2021

May 17, 2021

BUY
$28.09 - $34.02 $1.05 Million - $1.27 Million
37,344 Added 4.28%
910,046 $28.9 Million
Q4 2020

Feb 16, 2021

SELL
$20.44 - $30.88 $5.78 Million - $8.74 Million
-282,892 Reduced 24.48%
872,702 $26.1 Million
Q3 2020

Nov 16, 2020

BUY
$15.68 - $24.28 $504,049 - $780,504
32,146 Added 2.86%
1,155,594 $27.4 Million
Q2 2020

Aug 14, 2020

BUY
$10.56 - $18.46 $163,152 - $285,207
15,450 Added 1.39%
1,123,448 $17.9 Million
Q1 2020

May 15, 2020

BUY
$8.36 - $22.67 $295,250 - $800,636
35,317 Added 3.29%
1,107,998 $13.2 Million
Q4 2019

Feb 12, 2020

BUY
$15.73 - $21.81 $242,053 - $335,612
15,388 Added 1.46%
1,072,681 $23.1 Million
Q3 2019

Nov 14, 2019

BUY
$17.15 - $20.26 $443,241 - $523,619
25,845 Added 2.51%
1,057,293 $18.7 Million
Q2 2019

Aug 14, 2019

BUY
$15.13 - $20.34 $556,042 - $747,515
36,751 Added 3.69%
1,031,448 $21 Million
Q1 2019

May 15, 2019

BUY
$17.29 - $22.35 $476,218 - $615,586
27,543 Added 2.85%
994,697 $18.7 Million
Q4 2018

Feb 14, 2019

BUY
$16.79 - $21.0 $16.2 Million - $20.3 Million
967,154 New
967,154 $20.2 Million

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $431M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.